Davinder S Jassal
Overview
Explore the profile of Davinder S Jassal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
212
Citations
2455
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hassan-Tash P, Ismail U, Kirkpatrick I, Ravandi A, Jassal D, Hiebert B, et al.
Curr Probl Cardiol
. 2022 Oct;
48(2):101457.
PMID: 36273652
Cardiac output (CO) and other hemodynamic parameter measurements play an important role in the management of cardiovascular conditions; however, due to limitations of current day technologies, such measurements are either...
12.
Nagalingam R, Chattopadhyaya S, Al-Hattab D, Cheung D, Schwartz L, Jana S, et al.
Eur Heart J
. 2022 Oct;
43(45):4739-4750.
PMID: 36200607
Aims: In response to pro-fibrotic signals, scleraxis regulates cardiac fibroblast activation in vitro via transcriptional control of key fibrosis genes such as collagen and fibronectin; however, its role in vivo...
13.
Dhingra R, Rabinovich-Nikitin I, Rothman S, Guberman M, Gang H, Margulets V, et al.
Circulation
. 2022 Aug;
146(12):934-954.
PMID: 35983756
Background: Cytokines such as tumor necrosis factor-α (TNFα) have been implicated in cardiac dysfunction and toxicity associated with doxorubicin (DOX). Although TNFα can elicit different cellular responses, including survival or...
14.
Al-Shudiefat A, Ludke A, Malik A, Jassal D, Bagchi A, Singal P
Physiol Rep
. 2022 Aug;
10(15):e15379.
PMID: 35938295
We examined the beneficial effects of olive oil against heart failure post-myocardial infarction (PMI), induced by coronary artery ligation in rats. Animals were divided into sham and ligated groups and...
15.
Eekhoudt C, Bortoluzzi T, Varghese S, Cheung D, Christie S, Eastman S, et al.
Curr Oncol
. 2022 May;
29(5):2941-2953.
PMID: 35621631
Background: Two anti-cancer agents, doxorubicin (DOX) and trastuzumab (TRZ), are commonly used in the management of breast cancer in women. Despite their efficacy in reducing the morbidity and mortality of...
16.
Malik A, Bagchi A, Jassal D, Singal P
Biomedicines
. 2022 Apr;
10(4).
PMID: 35453640
The use of doxorubicin (Dox) in cancer patients carries the risk of cardiotoxicity via an increase in oxidative stress, mitochondrial dysfunction, and disturbed endoplasmic reticulum (ER) homeostasis in cardiomyocytes. The...
17.
Bews H, Bryson A, Bortoluzzi T, Tam J, Jassal D
CJC Open
. 2022 Feb;
4(5):497-500.
PMID: 35128370
COVID-19 vaccine-induced myocarditis is a rare adverse event in the current pandemic. The following is a case series of 10 individuals with COVID-19 vaccine-related myocarditis confirmed by cardiac magnetic resonance...
18.
Bews H, Bortoluzzi T, Jassal D
Eur Heart J Case Rep
. 2022 Jan;
5(12):ytab511.
PMID: 35047741
No abstract available.
19.
Bagchi A, Malik A, Akolkar G, Jassal D, Singal P
Antioxidants (Basel)
. 2021 Dec;
10(12).
PMID: 34943000
Doxorubicin (Dox) is known to cause heart failure in some cancer patients. Despite extensive studies over the past half century, the subcellular basis of Dox-induced cardiomyopathy (DIC) is still elusive....
20.
Varghese S, Johnston W, Eekhoudt C, Keats M, Jassal D, Grandy S
Curr Oncol
. 2021 Oct;
28(5):4139-4156.
PMID: 34677269
While developments in cancer therapeutics have greatly reduced morbidity and mortality in females with breast cancer, it comes at a cost of an increased risk of cardiovascular complications. In particular,...